| 000 | 01546 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514073305.0 | ||
| 264 | 0 | _c20031023 | |
| 008 | 200310s 0 0 eng d | ||
| 022 | _a0918-2918 | ||
| 024 | 7 |
_a10.2169/internalmedicine.42.529 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNakamori, Yoshitaka | |
| 245 | 0 | 0 |
_aPropylthiouracil (PTU)-induced vasculitis associated with antineutrophil antibody against myeloperoxidase (MPO-ANCA). _h[electronic resource] |
| 260 |
_bInternal medicine (Tokyo, Japan) _cJun 2003 |
||
| 300 |
_a529-33 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAntibodies, Antineutrophil Cytoplasmic _ximmunology |
| 650 | 0 | 4 | _aBlood Chemical Analysis |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGraves Disease _xdiagnosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPeroxidase _ximmunology |
| 650 | 0 | 4 |
_aPropylthiouracil _xadverse effects |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aThyroid Function Tests |
| 650 | 0 | 4 | _aTomography, X-Ray Computed |
| 650 | 0 | 4 |
_aVasculitis _xchemically induced |
| 700 | 1 | _aTominaga, Takayuki | |
| 700 | 1 | _aInoue, Yasushi | |
| 700 | 1 | _aShinohara, Kenji | |
| 773 | 0 |
_tInternal medicine (Tokyo, Japan) _gvol. 42 _gno. 6 _gp. 529-33 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2169/internalmedicine.42.529 _zAvailable from publisher's website |
| 999 |
_c12637429 _d12637429 |
||